Anika Therapeutics, Inc. (ANIK)
USD 14.69
(-2.39%)
USD 14.69
(-2.39%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.51 Million USD | 42.19% |
| 2022 | -4.91 Million USD | 50.98% |
| 2021 | 2.61 Million USD | -6345.44% |
| 2020 | -12.82 Million USD | -101.79% |
| 2019 | 34.24 Million USD | 57.47% |
| 2018 | 27.65 Million USD | -52.44% |
| 2017 | 50.01 Million USD | -9.64% |
| 2016 | 54.34 Million USD | 5.14% |
| 2015 | 51.9 Million USD | -21.67% |
| 2014 | 61.44 Million USD | 91.82% |
| 2013 | 32.03 Million USD | 29.21% |
| 2012 | 26.77 Million USD | 37.96% |
| 2011 | 17.96 Million USD | 65.5% |
| 2010 | 10.85 Million USD | -2.91% |
| 2009 | 11.18 Million USD | 97.6% |
| 2008 | 5.65 Million USD | -23.58% |
| 2007 | 7.4 Million USD | 27.44% |
| 2006 | 5.81 Million USD | -35.5% |
| 2005 | 9.01 Million USD | 26.94% |
| 2004 | 14.52 Million USD | 343.35% |
| 2003 | 1.6 Million USD | 173.47% |
| 2002 | -2.17 Million USD | 64.72% |
| 2001 | -6.17 Million USD | -2981.35% |
| 2000 | 214.37 Thousand USD | -73.2% |
| 1999 | 1.09 Million USD | -70.37% |
| 1998 | 3.37 Million USD | -15.63% |
| 1997 | 3.5 Million USD | 245.45% |
| 1996 | -2.1 Million USD | -37.5% |
| 1995 | -1.6 Million USD | -23.08% |
| 1994 | -1.2 Million USD | 18.75% |
| 1993 | -1.6 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -2.46 Million USD | -194.4% |
| 2024 Q2 | 2.21 Million USD | 218.54% |
| 2024 Q3 | -25.56 Million USD | -1245.7% |
| 2023 FY | - USD | 42.19% |
| 2023 Q1 | -9 Million USD | -35.02% |
| 2023 Q2 | -81 Thousand USD | 99.1% |
| 2023 Q4 | 2 Million USD | 126.06% |
| 2023 Q3 | -7.67 Million USD | -9374.07% |
| 2022 Q1 | 63 Thousand USD | 100.84% |
| 2022 Q2 | -3.38 Million USD | -5466.67% |
| 2022 FY | - USD | 50.98% |
| 2022 Q3 | -5.79 Million USD | -71.49% |
| 2022 Q4 | -6.66 Million USD | -14.99% |
| 2021 Q2 | -14.61 Million USD | -199.9% |
| 2021 FY | - USD | -6345.44% |
| 2021 Q4 | -7.47 Million USD | -269.22% |
| 2021 Q1 | -4.87 Million USD | -183.75% |
| 2021 Q3 | -2.02 Million USD | 86.15% |
| 2020 FY | - USD | -101.79% |
| 2020 Q1 | -3.56 Million USD | -174.14% |
| 2020 Q2 | -1.14 Million USD | 67.87% |
| 2020 Q4 | 5.82 Million USD | 50.12% |
| 2020 Q3 | 3.87 Million USD | 438.9% |
| 2019 FY | - USD | 57.47% |
| 2019 Q1 | 5.48 Million USD | -43.84% |
| 2019 Q2 | 11.91 Million USD | 117.35% |
| 2019 Q3 | 12.04 Million USD | 1.12% |
| 2019 Q4 | 4.8 Million USD | -60.15% |
| 2018 FY | - USD | -52.44% |
| 2018 Q4 | 9.76 Million USD | 13.87% |
| 2018 Q1 | -7.83 Million USD | -180.51% |
| 2018 Q3 | 8.57 Million USD | -23.77% |
| 2018 Q2 | 11.24 Million USD | 243.59% |
| 2017 Q4 | 9.72 Million USD | -5.27% |
| 2017 Q2 | 17.72 Million USD | 96.52% |
| 2017 Q1 | 9.02 Million USD | -29.2% |
| 2017 Q3 | 10.26 Million USD | -42.07% |
| 2017 FY | - USD | -9.64% |
| 2016 FY | - USD | 5.14% |
| 2016 Q4 | 12.74 Million USD | -6.93% |
| 2016 Q3 | 13.68 Million USD | 1.63% |
| 2016 Q2 | 13.46 Million USD | 25.77% |
| 2016 Q1 | 10.7 Million USD | -37.24% |
| 2015 Q4 | 17.06 Million USD | 29.91% |
| 2015 Q2 | 12.42 Million USD | 93.64% |
| 2015 Q1 | 6.41 Million USD | -46.9% |
| 2015 FY | - USD | -21.67% |
| 2015 Q3 | 13.13 Million USD | 5.68% |
| 2014 Q4 | 12.08 Million USD | 17.51% |
| 2014 Q3 | 10.28 Million USD | -32.34% |
| 2014 FY | - USD | 91.82% |
| 2014 Q1 | 23.87 Million USD | 122.21% |
| 2014 Q2 | 15.2 Million USD | -36.31% |
| 2013 FY | - USD | 29.21% |
| 2013 Q4 | 10.74 Million USD | 45.68% |
| 2013 Q3 | 7.37 Million USD | -19.64% |
| 2013 Q2 | 9.17 Million USD | 93.58% |
| 2013 Q1 | 4.74 Million USD | -63.16% |
| 2012 Q1 | 4.04 Million USD | -32.22% |
| 2012 Q4 | 12.86 Million USD | 371.9% |
| 2012 FY | - USD | 37.96% |
| 2012 Q3 | 2.72 Million USD | -55.55% |
| 2012 Q2 | 6.13 Million USD | 51.45% |
| 2011 Q1 | 1.47 Million USD | -55.81% |
| 2011 Q4 | 5.97 Million USD | 2.66% |
| 2011 FY | - USD | 65.5% |
| 2011 Q2 | 4.69 Million USD | 218.06% |
| 2011 Q3 | 5.81 Million USD | 23.88% |
| 2010 FY | - USD | -2.91% |
| 2010 Q3 | 2.87 Million USD | 9.89% |
| 2010 Q2 | 2.61 Million USD | 28.85% |
| 2010 Q4 | 3.34 Million USD | 16.37% |
| 2010 Q1 | 2.02 Million USD | -49.92% |
| 2009 Q2 | 1.54 Million USD | 41.17% |
| 2009 Q1 | 1.09 Million USD | -31.67% |
| 2009 FY | - USD | 97.6% |
| 2009 Q3 | 2.34 Million USD | 52.03% |
| 2009 Q4 | 4.05 Million USD | 72.72% |
| 2008 Q1 | 1.12 Million USD | -53.26% |
| 2008 Q4 | 1.59 Million USD | -4.34% |
| 2008 Q3 | 1.67 Million USD | 32.09% |
| 2008 FY | - USD | -23.58% |
| 2008 Q2 | 1.26 Million USD | 12.72% |
| 2007 Q2 | 1.54 Million USD | 11.94% |
| 2007 FY | - USD | 27.44% |
| 2007 Q4 | 2.4 Million USD | 16.08% |
| 2007 Q3 | 2.06 Million USD | 33.55% |
| 2007 Q1 | 1.38 Million USD | 44.09% |
| 2006 Q2 | 1.91 Million USD | 70.18% |
| 2006 Q4 | 960.81 Thousand USD | -46.84% |
| 2006 Q3 | 1.8 Million USD | -5.72% |
| 2006 Q1 | 1.12 Million USD | 15.77% |
| 2006 FY | - USD | -35.5% |
| 2005 FY | - USD | 26.94% |
| 2005 Q4 | 973 Thousand USD | -75.92% |
| 2005 Q3 | 4.04 Million USD | 94.04% |
| 2005 Q2 | 2.08 Million USD | 8.78% |
| 2005 Q1 | 1.91 Million USD | -25.7% |
| 2004 Q2 | 1.46 Million USD | 6.57% |
| 2004 FY | - USD | 343.35% |
| 2004 Q4 | 2.57 Million USD | 52.25% |
| 2004 Q3 | 1.69 Million USD | 15.89% |
| 2004 Q1 | 1.37 Million USD | 25.46% |
| 2003 Q1 | -261 Thousand USD | -129.44% |
| 2003 FY | - USD | 173.47% |
| 2003 Q4 | 1.09 Million USD | 69.83% |
| 2003 Q3 | 391 Thousand USD | 406.3% |
| 2003 Q2 | 127 Thousand USD | 148.66% |
| 2002 Q3 | -692.64 Thousand USD | 44.81% |
| 2002 FY | - USD | 64.72% |
| 2002 Q1 | -1.59 Million USD | -553.71% |
| 2002 Q2 | -947.24 Thousand USD | 40.64% |
| 2002 Q4 | 886.64 Thousand USD | 269.6% |
| 2001 FY | - USD | -2981.35% |
| 2001 Q4 | -244.12 Thousand USD | 77.48% |
| 2001 Q3 | -1.08 Million USD | 35.03% |
| 2001 Q1 | -2.06 Million USD | -187.31% |
| 2001 Q2 | -2.55 Million USD | 19.35% |
| 2000 Q4 | 2.36 Million USD | 265.75% |
| 2000 FY | - USD | -73.2% |
| 2000 Q3 | -1.42 Million USD | -642.04% |
| 2000 Q2 | -192.67 Thousand USD | 63.85% |
| 2000 Q1 | -532.96 Thousand USD | -366.48% |
| 1999 Q3 | - USD | -100.0% |
| 1999 Q2 | 233.34 Thousand USD | -16.67% |
| 1999 FY | - USD | -70.37% |
| 1999 Q1 | 600 Thousand USD | 20.0% |
| 1999 Q4 | 200 Thousand USD | 0.0% |
| 1998 Q2 | 2.1 Million USD | 800.0% |
| 1998 Q3 | 600 Thousand USD | -88.89% |
| 1998 Q4 | 800 Thousand USD | 150.0% |
| 1998 Q1 | 600 Thousand USD | -93.1% |
| 1998 FY | - USD | -15.63% |
| 1997 Q1 | 300 Thousand USD | 137.5% |
| 1997 Q3 | -200 Thousand USD | -140.0% |
| 1997 FY | - USD | 245.45% |
| 1997 Q2 | 500 Thousand USD | 66.67% |
| 1997 Q4 | 3.1 Million USD | 1550.0% |
| 1996 Q4 | -800 Thousand USD | -60.0% |
| 1996 Q3 | -500 Thousand USD | 28.57% |
| 1996 Q2 | -600 Thousand USD | 12.5% |
| 1996 Q1 | -1 Million USD | -100.0% |
| 1996 FY | - USD | -37.5% |
| 1995 FY | - USD | -23.08% |
| 1995 Q2 | -400 Thousand USD | -300.0% |
| 1995 Q4 | -400 Thousand USD | 50.0% |
| 1995 Q3 | -800 Thousand USD | -100.0% |
| 1995 Q1 | -100 Thousand USD | 75.0% |
| 1994 Q2 | -500 Thousand USD | -150.0% |
| 1994 Q4 | -400 Thousand USD | 0.0% |
| 1994 Q3 | -400 Thousand USD | 20.0% |
| 1994 FY | - USD | 18.75% |
| 1994 Q1 | -200 Thousand USD | -100.0% |
| 1993 FY | - USD | 0.0% |
| 1993 Q3 | -500 Thousand USD | -25.0% |
| 1993 Q2 | -400 Thousand USD | 0.0% |
| 1993 Q4 | -100 Thousand USD | 80.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 118.655% |
| Cerus Corporation | -26.53 Million USD | 109.481% |
| OrthoPediatrics Corp. | -8.38 Million USD | 130.02% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 123.974% |
| Talis Biomedical Corporation | -66.04 Million USD | 103.81% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 115.088% |
| Inogen, Inc. | -45.67 Million USD | 105.508% |
| Spectral AI, Inc. | -12.26 Million USD | 120.519% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 105.275% |
| CVRx, Inc. | -38.73 Million USD | 106.496% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 171.315% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 120.781% |
| Orthofix Medical Inc. | -86.98 Million USD | 102.892% |
| Venus Concept Inc. | -26.11 Million USD | 109.635% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 105.055% |
| Bioventus Inc. | -23.07 Million USD | 110.906% |
| BrainsWay Ltd. | -2.31 Million USD | 208.871% |
| Envoy Medical, Inc. | -18.23 Million USD | 113.795% |
| electroCore, Inc. | -17.76 Million USD | 114.167% |
| IceCure Medical Ltd | -15.25 Million USD | 116.495% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 105.057% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 114.927% |
| MaxCyte, Inc. | -44.12 Million USD | 105.702% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 121.402% |
| Nexalin Technology, Inc. | -5.69 Million USD | 144.202% |
| PAVmed Inc | -75.74 Million USD | 103.322% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 104.68% |
| RxSight, Inc. | -41.03 Million USD | 106.131% |
| Sight Sciences, Inc. | -49.41 Million USD | 105.092% |
| SI-BONE, Inc. | -34.44 Million USD | 107.304% |
| TELA Bio, Inc. | -40.63 Million USD | 106.192% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 104.316% |
| Treace Medical Concepts, Inc. | -39 Million USD | 106.45% |
| LivaNova PLC | 39.01 Million USD | 93.551% |
| 908 Devices Inc. | -34.02 Million USD | 107.395% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 102.275% |
| Nemaura Medical Inc. | -7.28 Million USD | 134.527% |
| NeuroPace, Inc. | -22.83 Million USD | 111.019% |
| LENSAR, Inc. | -8.71 Million USD | 128.873% |
| Apyx Medical Corporation | -18.11 Million USD | 113.891% |
| Cutera, Inc. | -136.56 Million USD | 101.842% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | 174.438% |
| BioSig Technologies, Inc. | -28.15 Million USD | 108.938% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 111.987% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 99.344% |
| Axonics, Inc. | 7.77 Million USD | 67.64% |
| Outset Medical, Inc. | -153.78 Million USD | 101.636% |
| IRIDEX Corporation | -7.44 Million USD | 133.781% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 102.565% |
| IRadimed Corporation | 20.8 Million USD | 87.904% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 131.208% |
| INVO Bioscience, Inc. | -6.88 Million USD | 136.57% |
| Telesis Bio, Inc. | -40.49 Million USD | 106.213% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 93.14% |
| Varex Imaging Corporation | 67.2 Million USD | 96.256% |
| Quipt Home Medical Corp. | 44.07 Million USD | 94.291% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 123.146% |
| Pulmonx Corporation | -55.09 Million USD | 104.567% |
| Dynatronics Corporation | -976 Thousand USD | 357.785% |
| Modular Medical, Inc. | -17.1 Million USD | 114.711% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 117.37% |
| Semler Scientific, Inc. | 23.58 Million USD | 89.334% |
| InMode Ltd. | 196.28 Million USD | 98.718% |
| Bruker Corporation | 599 Million USD | 99.58% |
| Cytosorbents Corporation | -28.81 Million USD | 108.733% |
| DexCom, Inc. | 916.7 Million USD | 99.726% |
| Align Technology, Inc. | 799.03 Million USD | 99.685% |
| Viveve Medical, Inc. | -20.61 Million USD | 112.204% |
| ZimVie Inc. | 91.07 Million USD | 97.237% |
| Movano Inc. | -29.12 Million USD | 108.639% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 157.078% |
| Nexalin Technology, Inc. | -5.69 Million USD | 144.202% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 171.315% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 101.293% |
| Profound Medical Corp. | -27.12 Million USD | 109.276% |
| Insulet Corporation | 323.6 Million USD | 99.222% |
| enVVeno Medical Corporation | -25.01 Million USD | 110.057% |
| Surmodics, Inc. | 1.18 Million USD | -111.785% |
| iCAD, Inc. | -6.56 Million USD | 138.324% |
| Nuwellis, Inc. | -16.35 Million USD | 115.383% |
| Biotricity, Inc. | -8.82 Million USD | 128.499% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 102.598% |
| Aethlon Medical, Inc. | -11.84 Million USD | 121.234% |
| InspireMD, Inc. | -20.91 Million USD | 112.032% |
| PAVmed Inc. | -75.74 Million USD | 103.322% |
| BIOLASE, Inc. | -15.13 Million USD | 116.619% |
| Beyond Air, Inc. | -59.03 Million USD | 104.262% |
| FONAR Corporation | 28.25 Million USD | 91.094% |
| AxoGen, Inc. | -13.32 Million USD | 118.878% |
| Vivani Medical, Inc. | -26.6 Million USD | 109.456% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 89.748% |
| Inari Medical, Inc. | 7.11 Million USD | 64.628% |
| UFP Technologies, Inc. | 72.74 Million USD | 96.541% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | 174.311% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 140.871% |
| Tenon Medical, Inc. | -15.52 Million USD | 116.203% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 116.481% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 106.066% |
| AdaptHealth Corp. | -171.09 Million USD | 101.471% |
| Sintx Technologies, Inc. | -6.6 Million USD | 138.121% |
| NanoVibronix, Inc. | -3.43 Million USD | 173.246% |
| Quanterix Corporation | -38.08 Million USD | 106.606% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 123.146% |
| Sensus Healthcare, Inc. | 30 Thousand USD | -8286.667% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 100.907% |
| TransMedics Group, Inc. | -7.6 Million USD | 133.092% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 111.56% |
| NeuroMetrix, Inc. | -7.09 Million USD | 135.458% |
| Hyperfine, Inc. | -47.06 Million USD | 105.346% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 104.315% |
| Biomerica, Inc. | -5.99 Million USD | 141.982% |
| Bone Biologics Corporation | 479.57 Thousand USD | -424.634% |
| AVITA Medical, Inc. | -39.56 Million USD | 106.359% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 127.429% |
| Silk Road Medical, Inc | -45.08 Million USD | 105.581% |